Company / Operating Cash Flow per Share
Traws Pharma, Inc. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$8.16
FY2024
5-year range
-$8.16 / -$0.19
FY2020-FY2024
Trend
-948.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -948% YoY in FY2024, a notable deviation from the 9-year average annual change of -362%.
Based on SEC 10-K filings.
-8.16 in FY2024.
Declined from $-0.93 to $-8.16 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 948.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$8.16 | -948.0% |
| FY2023 | -$0.78 | +16.5% |
| FY2022 | -$0.93 | +53.1% |
| FY2021 | -$1.99 | -960.5% |
| FY2020 | -$0.19 | +95.3% |
| FY2019 | -$4.00 | +87.9% |
| FY2018 | -$33.17 | -1318.1% |
| FY2017 | -$2.34 | +80.9% |
| FY2016 | -$12.27 | -361.8% |
| FY2015 | -$2.66 | -3591.9% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026